<sup>18</sup>F-FDG PET/CT在IgG4相关性疾病中的应用进展

朱冬灵; 邹思娟; 朱小华; 朱冬灵; 邹思娟; 朱小华

doi:10.3760/cma.j.issn.1673-4114.2015.01.012

[1]

Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease[J]. Curr Opin Rheumatol, 2011, 23(1):57-66. doi: 10.1097/BOR.0b013e3283418057

[2]

Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis[J]. N Engl J Med, 2001, 344(10):732-738. doi: 10.1056/NEJM200103083441005

[3]

Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis[J]. Lancet, 2002, 359(9315):1403-1404. doi: 10.1016/S0140-6736(02)08359-9

[4]

Yamamoto M, Ohara M, Suzuki C, et al. Elevated IgG4 concentrations in serum of patients with Mikulicz′s disease[J]. Scand J Rheumatol, 2004, 33(6):432-433.

[5]

Takahashi H, Yamamoto M, Suzuki CA, et al. The birthday of a new syndrome:IgG4-related diseases constitute a clinical entity[J]. Autoimmun Rev, 2010, 9(9):591-594. doi: 10.1016/j.autrev.2010.05.003

[6]

Hirabayashi K, Zamboni G. IgG4-related disease[J]. Pathologica, 2012, 104(2):43-55.

[7]

Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease(IgG4-RD), 2011[J]. Mod Rheumatol, 2012, 22(1):21-30. doi: 10.3109/s10165-011-0571-z

[8]

Takahashi H, Yamashita H, Morooka MA, et al. The utility of FDG-PET/CT and other imaging techniques in the evaluation of IgG4-related disease[J]. Joint Bone Spine, 2014, 81(4):331-336. doi: 10.1016/j.jbspin.2014.01.010

[9]

Ebbo M, Grados A, Guedj E, et al. Usefulness of 2-¹⁸F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease:a retrospective multicenter study[J]. Arthritis Care Res(Hoboken), 2014, 66(1):86-96. doi: 10.1002/acr.22058

[10]

Mahajan VS, Mattoo H, Deshpande V, et al. IgG4-Related disease[J]. Annu Rev Pathol, 2014, 9:315-347. doi: 10.1146/annurev-pathol-012513-104708

[11]

Proctor RD, Rofe CJ, Bryant T, et al. Autoimmune pancreatitis:An illustrated guide to diagnosis[J]. Clin Radiol, 2013, 68(4):422-432.

[12]

Santhosh S, Mittal BR, Bhasin DA, et al. Role of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses:Experience from tropics[J]. J Gastroenterol Hepatol, 2013, 28(2):255-261.

[13]

Nakajo M, Jinnouchi S, Fukukura YA, et al. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associa-ted extrapancreatic autoimmune lesions[J]. Eur J Nucl Med Mol Imaging, 2007, 34(12):2088-2095. doi: 10.1007/s00259-007-0562-7

[14]

Zhang J, Chen H, Ma Y, et al. Characterizing IgG4-related disease with ¹⁸F-FDG PET/CT:a prospective cohort study[J]. Eur J Nucl Med Mol Imaging, 2014, 41(8):1624-1634. doi: 10.1007/s00259-014-2729-3

[15]

Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations[J]. Arthritis Rheum, 2012, 64(10):3061-3067. doi: 10.1002/art.34593

[16]

Research Committee to establish diagnostic criteria and development of treatment for systemic IgG4-related sclerosing disease; Research Committee to establish a new clinical entity, IgG4-related multi-organ lymphoproliferative syndrome(IgG 4-MOLPS). Comprehensive diagnostic criteria for IgG4-related disease(IgG4-RD), 2011. Research Program of Intractable Disease provided by the Ministry of Health, Labor, and Welfare of Japan[J]. Nihon Naika Gakkai Zasshi. 2012, 101(3):795-804. doi: 10.2169/naika.101.795

[17]

Takuma K, Kamisawa T, Gopalakrishna R, et al. Strategy to differentiate autoimmune pancreatitis from pancreas cancer[J]. World J Gastroenterol, 2012, 18(10):1015-1020. doi: 10.3748/wjg.v18.i10.1015

[18]

Nakatani K, Nakamoto Y, Togashi K. Utility of FDG PET/CT in IgG4-related systemic disease[J]. Clin Radiol, 2012, 67(4):297-305.

[19]

Matsumoto I, Shinzeki M, Toyama H, et al. A focal mass-forming autoimmune pancreatitis mimicking pancreatic cancer with obstruction of the main pancreatic duct[J]. J Gastrointest Surg, 2011, 15(12):2296-2298. doi: 10.1007/s11605-011-1543-5

[20]

Himi T, Takano K, Yamamoto M, et al. A novel concept of Mikulicz′s disease as IgG4-related disease[J]. Auris Nasus Larynx, 2012, 39(1):9-17. doi: 10.1016/j.anl.2011.01.023

[21]

Yao Q, Wu G, Hoschar A. IgG4-related Mikulicz′s disease is a multi-organ lymphoproliferative disease distinct from Sjogren′s syndrome:a Caucasian patient and literature review[J]. Clin Exp Rheumatol, 2013, 31(2):289-294.

[22]

Ketwaroo GA, Sheth S. Autoimmune pancreatitis[J]. Gastroenterol rep(Oxf), 2013, 1(1):27-32.

[23]

Imdahl A, Nitzsche E, Krautmann F, et al. Evaluation of positron emission tomography with 2-[¹⁸F] fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer[J]. Br J Surg, 1999, 86(2):194-199.

[24]

Ozaki Y, Oguchi K, Hamano H, et al. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography[J]. J Gastroenterol, 2008, 43(2):144-151. doi: 10.1007/s00535-007-2132-y

[25]

Kawamura E, Habu D, Higashiyama SA, et al. A case of sclerosing cholangitis with autoimmune pancreatitis evaluated by FDG-PET[J]. Ann Nucl Med, 2007, 21(4):223-228.

[26]

Sato M, Okumura T, Shioyama Y, et al. Extrapancreatic F-18 FDG accumulation in autoimmune pancreatitis[J]. Ann Nucl Med, 2008, 22(3):215-219.

[27]

Suga K, Kawakami Y, Hiyama A, et al. F-18 FDG PET-CT findings in mikulicz disease and systemic involvement of IgG4-Related lesions[J]. Clin Nucl Med, 2009, 34(3):164-167.

[28]

Tomita H, Matsubayashi H, Sasaki K, et al. A case of autoimmune pancreatitis accompanied with Mikulicz′s disease[J]. Nihon Shokakibyo Gakkai Zasshi. 2010, 107(5):775-783.

[29]

Tabata R, Tabata C, Okamoto T, et al. Autoimmune pancreatitis associated with myelodysplastic syndrome[J]. Int Arch Allergy Immunol, 2010, 151(2):168-172.

[30]

Fukuhara H, Taniguchi Y, Matsumoto M, et al. IgG4-related tubulointerstitial nephritis accompanied with cystic formation[J]. BMC Urol, 2014, 14:54. doi: 10.1186/1471-2490-14-54

[31]

Matsubayashi H, Furukawa H, Maeda AA, et al. Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis[J]. Pancreatology, 2009, 9(5):694-699. doi: 10.1159/000199439

[32]

张建, 余仲飞, 胡胜平, 等. ¹⁸F-FDG PET/CT在自身免疫性胰腺炎诊断及全身评价中的应用.中华胰腺病杂志, 2014, 14(4):247-251. doi: 10.3760/cma.j.issn.1674-1935.2014.04.009

[33]

Agaimy A, Weyand M, Strecker T. Inflammatory thoracic aortic aneurysm(lymphoplasmacytic thoracic aortitis):a 13-year-experience at a German Heart Center with emphasis on possible role of IgG4[J]. Int J Clin Exp Pathol, 2013, 6(9):1713-1722.

[34]

Holubec T, Laco J, Holubcova Z, et al. Repair of thoracic aortic aneurysm due to noninfectious aortitis[J]. J Card Surg, 2012, 27(2):199-204. doi: 10.1111/j.1540-8191.2011.01399.x

[35]

Kamisawa T, Okazaki K, Kawa SA, et al. Japanese consensus guidelines for management of autoimmune pancreatitis:Ⅲ. Treatment and prognosis of AIP[J]. J Gastroenterol, 2010, 45(5):471-477. doi: 10.1007/s00535-010-0221-9

[36]

邓雪蓉, 张卓莉. IgG4相关疾病合并淋巴瘤一例[J].中华风湿病学杂志, 2014, 18(8):574-576, 后插1. doi: 10.3760/cma.j.issn.1007-7480.2014.08.020

[37]

Radu CG, Shu CJ, Nair-Gill E, et al. Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new[(18)F]-labeled 2'-deoxycytidine analog[J]. Nat Med, 2008, 14(7):783-788. doi: 10.1038/nm1724